faghy

Patient and public involvement and engagement in Long COVID research: embedding inclusion in research Abstract Background Patient and public involvement and engagement (PPIE) is increasingly recognised as essential to ensuring that research is safe, inclusive and equitable, yet...

Whole body fluorine-18 fluorodeoxyglucose parametric PET/computed tomography in people with long coronavirus disease: the ERASE-LC trial protocol Abstract The ERASE-LC feasibility trial will evaluate the feasibility of using remdesivir for the treatment of long coronavirus disease (COVID)...

An Open-Label Feasibility Study of Remdesivir in Long COVID: Results from the ERASE LC Trial Objective Treatment of acute COVID-19 with anti-viral and immunomodulator medications demonstrates a reduced risk of long-term outcomes. To date, remdesivir, an intravenous (IV) antiviral that...

https://islc-pais.com/ A United Scientific Response The International Society of Long COVID and Post-Acute Infection Syndromes — a global coalition of clinicians, researchers and advocates advancing evidence-based care. MISSION To advance the global understanding, diagnosis, treatment...

An open-label, clinical feasibility study of the efficacy of Remdesivir for Long-COVID BACKGROUND Long COVID (LC) affects around two million people in the UK and over 65 million people globally. Antiviral medications have shown positive effects in reducing the risk of progression to severe...

Mark A. Faghy, Rob C. I. Wüst, Daniel M. Altmann, Ruth EM Ashton, Sarah Barley McMullen, Rae Duncan, Andrew G. Ewing, Elke Hausmann, Sanjay Gupta, Mady Hornig, David Joffe, Binita Kane, M. Asad Khan, Micheal Natt, Rebecca Owen, David Putrino, Lindsay Skipper, Claire Taylor, Callum Thomas, David...

Abstract Long COVID (LC) is a multisystem condition that is linked to distinct pathologies including viral persistence, immunological dysfunction, endothelial damage, and mitochondrial dysfunction. To date, limited research has assessed peripheral tissue hypoxia to better understand LC symptom...

Co-creating a social science research agenda for Long Covid Cousins, Oonagh; Jokela-Pansini, Maaret; Alwan, Nisreen A; Barnard, Ella; Dainow, Jo; Dalton, Caroline; Davies, Gail; Faghy, Mark A; Gilmour, Eileen; Patel, Ian; Sherwood, Ondine; Westerhof, Lotus; Greenhough, Beth INTRODUCTION Our...

Profiling the persistent and episodic nature of long COVID symptoms and the impact on quality of life and functional status: a cohort observation study https://jogh.org/2025/jogh-15-04006 Abstract Background Post-viral issues following acute infection with coronavirus disease 2019 (COVID-19)...

Priorities for Research, Education, Clinical Practice, and Policy From the Long COVID Physio International Forum McDuff, Kiera; Brown, Darren A.; Gross, Douglas P.; Faghy, Mark A.; Davenport, Todd E.; Audette, Jennifer; Bassi, Laura; Bull, Michelle; Cobbing, Saul E.; Décary, Simon; Flynn...

Highlights Lactate monitoring has the potential to extend beyond applied sports settings and could be used to monitor the physiologic and pathophysiological responses to external and internal stimuli in chronic disease areas such as Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)...

Moved posts from this thread BBC Article https://www.bbc.co.uk/news/uk-england-derbyshire-67081243 Antiviral treatment for 100 LC patients (2+ years) i think under Faghy. Comment by him and David Strain. Faghy posted on TwitterX. edited for spelling

"The value of clinical cardiopulmonary exercise testing (CPET) within healthcare settings has been established in the last decade. CPET methods remain highly relevant in the COVID-19 endemic phase and should be used to assess those recovering from COVID-19 infection. This diagnostic tool could...

Abstract Curtailing elite sports during the coronavirus disease 2019 (COVID-19) pandemic was necessary to prevent widespread viral transmission. Now that elite sport and international competitions have been largely restored, there is still a need to devise appropriate screening and management...

Graphic summary of of the key messages highlighted in the paper positioning Long COVID as a global health concern. https://jogh.org/2022/jogh-12-03067

Abstract Background Long-COVID diagnosis is prominent, and our attention must support those experiencing debilitating and long-standing symptoms. To establish patient pathways, we must consider the societal and economic impacts of sustained COVID-19. Accordingly, we sought to determine the...